Kumar, S. (2024) “A Real World Analysis of Safety and Efficacy of Nilotinib when Used as First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated with Nilotinib”, Asian Pacific Journal of Cancer Biology, 9(2), pp. 137–147. doi: 10.31557/apjcb.2024.9.2.137-147.